| Title: |
Efficacy and Safety Outcomes with Diroximel Fumarate After Switching from Prior Therapies or Continuing on DRF: Results from the Phase 3 EVOLVE-MS-1 Study |
| Authors: |
Wray, SibylAff1; Then Bergh, FlorianAff2; Wundes, AnnetteAff3; Arnold, Douglas L.Aff4, Aff5; Drulovic, JelenaAff6; Jasinska, ElzbietaAff7; Bowen, James D.Aff8; Negroski, DonaldAff9; Naismith, Robert T.Aff10; Hunter, Samuel F.Aff11; Gudesblatt, MarkAff12; Chen, HailuAff13; Lyons, JenniferAff13; Shankar, Sai L.Aff13; Kapadia, ShivaniAff13; Mendoza, Jason P.Aff13, IDs12325022020687_cor16; Singer, Barry A.Aff14 |
| Source: |
Advances in Therapy. 39(4):1810-1831 |
| Database: |
Springer Nature Journals |